Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkata K Pokuri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Oncology Reports|January 9, 2016
Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine TumorsVenkata K Pokuri, Mei Ka Fong, Renuka Iyer
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Interdigitating dendritic cell sarcomaVenkata K Pokuri, Mihai Merzianu, Shipra Gandhi, et al.
The Journal of Community and Supportive Oncology|March 9, 2016
A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinomaVenkata K Pokuri, Norbert Sule, Caroline Perfetto, et al.
Plos One|June 12, 2018
Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based studySandeep Samuel, Sarbajit Mukherjee, Nischala Ammannagari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment ParadigmsVenkata K Pokuri, Houman Nourkeyhani, Bodie Betsy, et al.
Annals of Hematology|February 11, 2015
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapyVenkata K Pokuri, Bo Xu, Vishala Neppalli, et al.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Journal of Gastrointestinal Oncology|June 11, 2016
Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experienceSmit Singla, Charles M LeVea, Venkata K Pokuri, et al.
Clinical Genitourinary Cancer|October 29, 2015
Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CarcinomaVenkata K Pokuri, Johar R Syed, Zhengyu Yang, et al.
American Journal of Clinical Oncology|March 26, 2016
Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II TrialVenkata K Pokuri, Garin M Tomaszewski, Sihem Ait-Oudhia, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Oncology Reports|January 9, 2016
Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine TumorsVenkata K Pokuri, Mei Ka Fong, Renuka Iyer
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Interdigitating dendritic cell sarcomaVenkata K Pokuri, Mihai Merzianu, Shipra Gandhi, et al.
The Journal of Community and Supportive Oncology|March 9, 2016
A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinomaVenkata K Pokuri, Norbert Sule, Caroline Perfetto, et al.
Plos One|June 12, 2018
Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based studySandeep Samuel, Sarbajit Mukherjee, Nischala Ammannagari, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment ParadigmsVenkata K Pokuri, Houman Nourkeyhani, Bodie Betsy, et al.
Annals of Hematology|February 11, 2015
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapyVenkata K Pokuri, Bo Xu, Vishala Neppalli, et al.
American Journal of Clinical Oncology|November 17, 2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract CancerRenuka V Iyer, Venkata K Pokuri, Adrienne Groman, et al.
Journal of Gastrointestinal Oncology|June 11, 2016
Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experienceSmit Singla, Charles M LeVea, Venkata K Pokuri, et al.
Clinical Genitourinary Cancer|October 29, 2015
Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CarcinomaVenkata K Pokuri, Johar R Syed, Zhengyu Yang, et al.
American Journal of Clinical Oncology|March 26, 2016
Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II TrialVenkata K Pokuri, Garin M Tomaszewski, Sihem Ait-Oudhia, et al.
Pageof 1